Pharma Journalist - Page 841 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Pfizer Reviewing Strategic Alternatives for Consumer Healthcare Business

Flexion announces FDA Approval of Zilretta for Osteoarthritis (OA) Knee Pain

Health Canada accepts Mithra’s marketing authorization application for Tibelia

MilliporeSigma Opens New Life Science Center in Massachusetts

BioTime Announces First Patient in U.S. Clinical Trial Treated for Facial Volume Deficit

Izun Pharmaceuticals Announces Positive Results from Phase 2 Double Blind Oral Mucositis Trial

First Patient Treated With Titan Pharmaceuticals’ Subdermal Implant For Parkinson’s Disease

Janssen submits New Drug Application to FDA for Apalutamide (ARN-509)

Moffitt Researchers Discover New Targets for Approved Cancer Drug

Kaleido Biosciences & CoreBiome Partner to Accelerate Microbiome Therapeutic Development